ELAN PHARMA INTERNATIONAL LIMITED
Patent Owner
Stats
- 24 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Jul 11, 2017 most recent publication
Details
- 24 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 14,833 Total Citation Count
- Nov 18, 1986 Earliest Filing
- 172 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9701746 Methods of treating neuropathic pain with specific binding members for NGFApr 18, 16Jul 11, 17[A61K, C07K]
6843782 Pre-filled drug-delivery device and method of manufacture and assembly of sameApr 18, 01Jan 18, 05[A61M]
6824529 Pre-filled drug-delivery device and method of manufacture and assembly of sameApr 17, 01Nov 30, 04[A61M]
6585707 Drug delivery device having improved adhesion and attachment system for drug delivery deviceMay 20, 99Jul 01, 03[A61F]
6520941 Method and device for entrapping gas within a liquid drug containerOct 12, 99Feb 18, 03[B65D, A61M]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0172,279 COMPOSITION FOR TOPICAL TREATMENT OF MIXED VAGINAL INFECTIONSAbandonedJul 25, 12Jul 04, 13[A61K]
2012/0128,780 NANOPARTICULATE BISPHOSPHONATE COMPOSITIONSAbandonedOct 17, 11May 24, 12[A61K, B82Y, A61P]
2012/0087,984 STABILIZATION OF CHEMICAL COMPOUNDS USING NANOPARTICULATE FORMULATIONSAbandonedOct 03, 11Apr 12, 12[A61K, B82Y, C07D, A61P]
2012/0003,319 COMPOSITIONS FOR SITE-SPECIFIC DELIVERY OF IMATINIB AND METHODS OF USEAbandonedMar 19, 09Jan 05, 12[A61K]
8017348 Assay for Parkinson's Disease therapeuticsExpiredJul 21, 08Sep 13, 11[C12Q, C12N, G01N, C40B]
2011/0182,893 PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASESAbandonedFeb 23, 11Jul 28, 11[A61K, A61P]
2011/0177,066 PREVENTION AND TREATMENT OF AMYLOIDOGENIC DISEASESAbandonedFeb 23, 11Jul 21, 11[A61K, A61P]
2011/0159,054 NANOPARTICULATE BICALUTAMIDE FORMULATIONSAbandonedMar 02, 11Jun 30, 11[A61K, B82Y, C07C, A61P]
2011/0064,800 NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING CYCLOSPORINEAbandonedSep 23, 10Mar 17, 11[A61K, B82Y, A61P]
2011/0064,803 NANOPARTICULATE AND CONTROLLED RELEASE COMPOSITIONS COMPRISING VITAMIN K2AbandonedMay 09, 06Mar 17, 11[A61K, A61P]
2011/0027,371 Nanoparticulate statin formulations and novel statin combinationsAbandonedMar 06, 06Feb 03, 11[A61K, A61P]
2011/0008,435 Nanoparticulate and Controlled Release Compositions Comprising Aryl-Heterocyclic CompoundsAbandonedFeb 07, 07Jan 13, 11[A61K, A61P]
2010/0329,976 NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORSAbandonedAug 27, 10Dec 30, 10[A61K]
2010/0322,852 NANOPARTICULATE COMPOSITIONS OF ANGIOGENESIS INHIBITORSAbandonedAug 27, 10Dec 23, 10[A61K, A61P]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.